期刊
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
卷 105, 期 14, 页码 5620-5625出版社
NATL ACAD SCIENCES
DOI: 10.1073/pnas.0801453105
关键词
hypertonicity; reactive oxygen species; transcription; HEK293 cells; mIMCD3 cells
资金
- Intramural NIH HHS Funding Source: Medline
High NaCl rapidly activates p38 MAPK by phosphorylating it, the phosphorylation presumably being regulated by a balance of kinases and phosphatases. Kinases are known, but the phosphatases are uncertain. Our initial purpose was to identify the phosphatases. We find that in HEK293 cells transient overexpression of MAPK phosphatase-1 (MKP-1), a dual-specificity phosphatase, inhibits high NaCl-induced phosphorylation of p38, and that overexpression of a dominant negative mutant of MKP-1 does the opposite. High NaCl lowers MKP-1 activity by increasing reactive oxygen species, which directly inhibit MKP-1, and by reducing binding of MKP-1 to p38. Because inhibition of p38 is reported to reduce hypertonicity-induced activation of the osmoprotective transcription factor, TonEBP/OREBP, we anticipated that MKP-1 expression might also. However, overexpression of MKP-1 has no significant effect on Ton EBP/OREBP activity. This paradox is explained by opposing effects of p38 alpha and p38 delta, both of which are activated by high NaCl and inhibited by MKP-1. Thus, we find that overexpression of p38 alpha increases high NaCl-induced TonEBP/OREBP activity, but overexpression of p38 delta reduces it. Also, siRNA-mediated knockdown of p38 delta enhances the activation of TonEBP/OREBP. We conclude that high NaCl inhibits MKP-1, which contributes to the activation of p38. However, opposing actions of p38 alpha and p38 delta negate any effect on TonEBP/OREBP activity. Thus, activation of p38 isoforms by hypertonicity does not contribute to activation of TonEBP/OREBP because of opposing effects of p38 alpha and p38 delta, and effects of inhibitors of p38 depend on which isoform is affected, which can be misleading.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据